Source: Health Canada shortage reports · Updated Aug 7, 2026
A shortage of Gemcitabine is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 / 9
Reports on file
21
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Apr 25, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Apr 19, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Apr 19, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Feb 15, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Jan 24, 2024 · Disruption of the manufacture of the drug.
Avoided
GEMCITABINE INJECTION
38MG · SOLUTION · PFIZER CANADA ULC
DIN 02402831 · ended Jan 24, 2024 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
40MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02412292 · ended Dec 23, 2022 · Delay in shipping of the drug.
Discontinued
GEMCITABINE FOR INJECTION
TEVA CANADA LIMITED
DIN 02305534
Resolved
GEMCITABINE FOR INJECTION
1G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02305534 · ended Jun 30, 2018 · Disruption of the manufacture of the drug.
Resolved
GEMCITABINE INJECTION
40MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02412292 · ended Aug 6, 2019 · Delay in shipping of the drug.
Discontinued
ACT GEMCITABINE
38MG · SOLUTION · ACTAVIS PHARMA COMPANY
DIN 02433117
Showing 12 of 21 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Gemcitabine to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Gemcitabine is classified under “ANTIMETABOLITES” (ATC L01BC).
Recent changes
Aug 7, 2026
New report filed
Common questions
When will Gemcitabine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Gemcitabine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.